Molecular cancer research : MCR
Non-clear-cell renal cell carcinoma has an immune cold phenotype that impacts response to immune checkpoint inhibitors.
Hiroki Ishihara, Yu-Yu Liu, Riu Yamashita, Hironori Fukuda, Yukihiro Mizoguchi, Makiko Yamashita, Shigehisa Kitano, Kazunori Aoki, Hidekazu Tachibana, Shinsuke Mizoguchi, Koichi Nishimura, Takayuki Nakayama, Yuki Nemoto, Kazuhiko Yoshida, Toshihito Hirai
Published: 202610.1158/1541-7786.MCR-25-0939
Abstract
Data regarding the clinical outcomes of immune checkpoint inhibitor (ICI) therapy and tumor immune microenvironment (TIME) profiles in non-clear-cell renal cell carcinoma (nccRCC) remain limited. Herein, we retrospectively compared the effectiveness…
Preview only. Read the full abstract at the source